SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-007644
Filing Date
2014-02-11
Accepted
2014-02-11 16:59:40
Documents
8
Period of Report
2014-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v367950_8k.htm 8-K 29300
2 EXHIBIT 1.1 v367950_ex1-1.htm EX-1.1 252107
3 EXHIBIT 4.1 v367950_ex4-1.htm EX-4.1 1018438
4 EXHIBIT 4.3 v367950_ex4-3.htm EX-4.3 173708
5 EXHIBIT 99.1 v367950_ex99-1.htm EX-99.1 5644
6 EXHIBIT 99.2 v367950_ex99-2.htm EX-99.2 5534
7 GRAPHIC tex99-1_logo.jpg GRAPHIC 8076
8 GRAPHIC image_003.jpg GRAPHIC 2616
  Complete submission text file 0001144204-14-007644.txt   1501089
Mailing Address 100 CLEARBROOK ROAD ELMSFORD NY 10523
Business Address 100 CLEARBROOK ROAD ELMSFORD NY 10523 914 460 1600
BioScrip, Inc. (Filer) CIK: 0001014739 (see all company filings)

IRS No.: 050489664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28740 | Film No.: 14595039
SIC: 5912 Retail-Drug Stores and Proprietary Stores